Malignant neoplasm of spinal meninges
ICD-10 C70.1 is a billable code used to indicate a diagnosis of malignant neoplasm of spinal meninges.
Malignant neoplasm of the spinal meninges refers to a cancerous growth that originates in the protective membranes surrounding the spinal cord. This condition can arise from primary tumors of the meninges or can be a result of metastasis from other malignancies. Symptoms may include back pain, neurological deficits, and signs of increased intracranial pressure. Diagnosis typically involves imaging studies such as MRI or CT scans, which can reveal the presence of tumors, their size, and their impact on surrounding structures. Treatment options may include surgical resection, radiation therapy, and chemotherapy, depending on the tumor's characteristics and the patient's overall health. Molecular markers may also be evaluated to guide treatment decisions and prognostication. Neurological function can be significantly affected, necessitating a multidisciplinary approach to management, including neurology, oncology, and rehabilitation services.
Comprehensive treatment plans, imaging results, and pathology reports.
Diagnosis and management of spinal meningeal tumors, treatment response evaluation.
Ensure accurate staging and grading of tumors for appropriate coding.
Neurological assessments, imaging studies, and functional status evaluations.
Assessment of neurological deficits related to spinal tumors.
Document neurological examinations thoroughly to support coding.
Used during surgical intervention for spinal tumors.
Document the surgical approach and findings.
Ensure coordination between neurosurgery and oncology for comprehensive care.
MRI or CT scans are essential for diagnosing malignant neoplasms of the spinal meninges. Documentation of these studies must be included in the patient's medical record.
